Navigation Links
Amgen to Present at the Barclays Capital Global Healthcare Conference
Date:3/9/2009

THOUSAND OAKS, Calif., March 9 /PRNewswire-FirstCall/ -- Amgen (Nasdaq: AMGN) will present at the Barclays Capital Global Healthcare Conference on Wednesday, March 11, 2009 at the Loews Miami Beach Hotel, Miami Beach, Fla., beginning at 9:00 a.m. Eastern Time. Amgen's Chief Financial Officer Robert A. Bradway will present. Live audio of the presentation will be available over the Internet and can be accessed from Amgen's Web site, www.amgen.com, under Investors.

Information regarding presentation time, webcast availability, and webcast links are available on Amgen's Investor Relations Events Calendar.

About Amgen

Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe and effective medicines from lab, to manufacturing plant, to patient. Amgen therapeutics have changed the practice of medicine, helping millions of people around the world in the fight against cancer, kidney disease, rheumatoid arthritis, and other serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. To learn more about our pioneering science and our vital medicines, visit www.amgen.com.

    CONTACT: Amgen, Thousand Oaks
    David Polk, 805-447-4613 (media)
    Justin Claeys, 805-447-1060 (investors)

(Logo: http://www.newscom.com/cgi-bin/prnh/20081015/AMGENLOGO)


'/>"/>
SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1

Related medicine news :

1. OmniPod(R) Insulin Management System Lets Team Type 1 Members Focus on Competing at Amgen Tour of California
2. InteKrin Therapeutics, Inc. Appoints Former Amgen Clinical Development Executive Chief Medical Officer
3. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
4. Masimo to Present at the Cowen and Company 29th Annual Healthcare Conference
5. ProteoTech to Present at 9th International Conference for Alzheimers and Parkinsons Disease - Prague, Czech Republic, March 11-15, 2009
6. Brookdale to Present at Barclays Capital Global Healthcare Conference March 11
7. Destination Fashion 2009 Presented by Stewart Rahr -
8. West to Present at the 2009 Barclays Global Healthcare Conference
9. Beckman Coulter to Present at Upcoming Healthcare Conferences
10. Savient Pharmaceuticals to Present at The Cowen and Company 29th Annual Healthcare Conference on March 17, 2009
11. Covance to Present at the Barclays Capital Global Healthcare Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...tients and survivors treated with chemotherapy suf...chronic conditions, hindering patients, ability to...versity of Rochester Medical Center. , A study o...p troubles at nearly three times the rate of the g...in younger patients and those with lung and breast...
(Date:11/23/2009)...ing chemo deal with insomnia, study shows , ... and sleep disorders affect more than three-quarte...ate nearly three times higher than that of the gen...em is more common in younger patients and in those...Rochester Medical Center researchers, who assessed...
(Date:11/23/2009)...23/PRNewswire/--Hazelden,theinternationallyrenowne...heleadershipteamforitsnewrecoverycenterinNaples,Fl...oopeninlateMarch2010,andwillinitiallyprovideaddict...ffamilyandoutpatientservices. ,, MichaelDemask,...lityinNaples,withBrendaIliff,M.A.,L.A.D.C.,asclini...
(Date:11/23/2009)...ewswire-USNewswire/-- The AmericanLegislativeExch...bershipassociationofstatelegislators,congratulates...ilinga constitutionalamendment toprotecttherightof...rolinanowbecomesthe24thstatewherelegislatorshavein...EC,s FreedomofChoiceinHealthCareAct . ,, (Logo:...
(Date:11/23/2009)...or Science Writings at Stevens Institute of Techno...y Robert Wright, journalist and founder, Bloggingh...m. at the Babbio Center for Technology Management,...c and the media., In his new book "The Evolution..., renowned for his popular works on evolutionary p...
Breaking Medicine News(10 mins):Health News:Insomnia prevalent among cancer patients who receive chemotherapy 2Health News:Hazelden Names Leadership Team for New Recovery Center in Naples, Florida 2Health News:South Carolina Now 24th State to Defend Health Care Choice 2
...entered the antismoking segment with its "Smoquit"...in Smoquit has been used for over a decade as an a... 13.50-per tablet priced Smoquit, the first pharma...ce. // Smoking causes or predisposes a perso...
...ssive smoking has a lasting impact on the respirat...National Center for Environmental Health in Atlant...ars. The researchers analysed the children's...d that passive smoking had the strongest impact on...
...enes more than 30 per cent higher. At around 30,00... sequence seemed scanty compared with the mustard ...el Cooke and colleagues at the Genomics Institute ...earchers detect the activity of some of the genes ...
...nding researchers who have pioneered a new drug, k...d supply directly. It represents a new approa...sels that feed a tumour, as well as activating the... to leak and break down. Due to restriction of its...
...iac arrest and are easier to use. Nearly quarter ...ear in the United States.// Many lives could be sa..., using an automated electrical defibrillator (AED...n staff to use them. But most cardiac arrest...
...r antioxidant effects than orange juice. according...food. The study states that, people who are ...ough increased antioxidant consumption might prefe...hor of the study. "In our tests, we saw dramatical...
Other Medicine News:
(Date:11/23/2009)...er.comannouncesthatanewmarketresearchreportisavail...-AGlobalMarketReview ,, http://www.reportlin...bal-Market-Review.html#utm_source=prnewswire&u... Cardiovascularmonitoringisextremelybeneficialforc...lymonitoredduringdiagnosticaswellaspatientcarestag...
(Date:11/23/2009)...er.comannouncesthatanewmarketresearchreportisavail...WorldMarketReview ,, http://www.reportlinker...ket-Review.html#utm_source=prnewswire&utm_medi...generalanesthesiadisposablesmarketischaracterizedb...ewitnessedingeneralsurgicalprocedures,growingpopul...
(Date:11/23/2009)...RNewswire-USNewswire/--JubilantOrganosys,theUniver...Institutetodayannouncedajointventurethatwillfocuso...hnologiesintheareasofOncology,MetabolicDiseaseandI...ndleveragedpartnershipthatwillacceleratethedevelop...orandumofUnderstandingwassignedtodayinWashington,D...
Breaking Medicine Technology:Reportlinker Adds Holter Monitoring Systems - A Global Market Review 2Reportlinker Adds Holter Monitoring Systems - A Global Market Review 3Reportlinker Adds Holter Monitoring Systems - A Global Market Review 4Reportlinker Adds Holter Monitoring Systems - A Global Market Review 5Reportlinker Adds Anesthesia Disposables - A World Market Review 2Reportlinker Adds Anesthesia Disposables - A World Market Review 3Reportlinker Adds Anesthesia Disposables - A World Market Review 4Reportlinker Adds Anesthesia Disposables - A World Market Review 5Reportlinker Adds Anesthesia Disposables - A World Market Review 6Jubilant Organosys, UAB and Southern Research Enter Into Drug Discovery Joint Venture 2Jubilant Organosys, UAB and Southern Research Enter Into Drug Discovery Joint Venture 3Jubilant Organosys, UAB and Southern Research Enter Into Drug Discovery Joint Venture 4Link found between common sexual infection and risk of aggressive prostate cancer 56681 1Link found between common sexual infection and risk of aggressive prostate cancer 56681 2UAB researchers looking for genetic predictors for suicide 9855 1UAB researchers looking for genetic predictors for suicide 9855 2Blue Shield of California to Cover H1N1 Flu Vaccine Administration for All Members 56676 1Blue Shield of California to Cover H1N1 Flu Vaccine Administration for All Members 56676 2
...gies, Inc. (Nasdaq: RMTI ), a leading, innovative...ecialty pharmaceuticals focused on the end-,stage-...it has begun dosing,patients in its Phase IIb Dose...sphate (SFP), the Company,s physiological iron-mai...ign is a double-blind, multi-center,randomized, pl...
...als,Inc., a privately-held biopharmaceutical compa...hronic and acute inflammatory diseases,announced t...ng in its,Phase II clinical study of its lead comp...ta analysis is scheduled to be completed by the en...ollment of this study and look,forward to reportin...
Other Medicine Technology:Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study 2Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study 3Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study 4Anthera Announces Completion of Enrollment and Dosing in Phase II Trial of A-002 for the Treatment of Cardiovascular Disease 2Anthera Announces Completion of Enrollment and Dosing in Phase II Trial of A-002 for the Treatment of Cardiovascular Disease 3
Thermal Seal, Clear
Mylar Plate Sealers
OptiTape Roll with dispenser. 250 pk.
Eppendorf Heat Sealing Film
Medicine Products: